Absolute Return Capital’s Novo Nordisk NVO Stock Holding History

Absolute Return Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-401,350	Closed	-$7.42M	–	1280
2013 Q4	$7.42M	Hold	401,350	–	–	0.08%	277
2013 Q3	$6.79M	Buy	+401,350	New	+$6.75M	0.09%	281

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Absolute Return Capital's NVO Position: Q1 2014 in Review

Absolute Return Capital sold out of Novo Nordisk (NVO) in Q1 2014, closing a stake of 401,350 shares — an estimated $7.42M sold.

Absolute Return Capital first reported a position in NVO in Q3 2013 and held it in 2 quarters. The position peaked at $7.42M in Q4 2013. 461 funds tracked by Wall St. Rank hold NVO as of Q1 2014.

Absolute Return Capital reported no remaining Novo Nordisk position as of Q1 2014 after selling out during the quarter.
Absolute Return Capital sold 401,350 Novo Nordisk shares in Q1 2014, an estimated $7.42M.
Absolute Return Capital first reported a position in Novo Nordisk in Q3 2013 and held it in 2 quarters.
Absolute Return Capital's Novo Nordisk position peaked at $7.42M in Q4 2013.
461 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2014.

Based on Absolute Return Capital's 13F filing for Q1 2014, filed 15 May 2014.